InnovAge Holding Corp. (INNV)
USD 3.75
(-8.09%)
USD 3.75
(-8.09%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 132.06 Million USD | 30.38% |
| 2023 | 101.28 Million USD | -25.18% |
| 2022 | 135.37 Million USD | -22.24% |
| 2021 | 174.08 Million USD | 23.2% |
| 2020 | 141.3 Million USD | 27.73% |
| 2019 | 110.62 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 132.06 Million USD | 30.38% |
| 2024 Q2 | 33.61 Million USD | 20.58% |
| 2024 Q4 | 36.57 Million USD | 26.41% |
| 2024 Q1 | 27.87 Million USD | -2.21% |
| 2024 Q3 | 28.93 Million USD | -13.92% |
| 2023 Q3 | 28.78 Million USD | 27.52% |
| 2023 FY | 101.28 Million USD | -25.18% |
| 2023 Q4 | 28.5 Million USD | -0.97% |
| 2023 Q2 | 22.57 Million USD | 5.36% |
| 2023 Q1 | 21.42 Million USD | -9.34% |
| 2022 Q3 | 28 Million USD | -32.37% |
| 2022 Q4 | 23.63 Million USD | -15.61% |
| 2022 Q1 | 42.33 Million USD | -11.87% |
| 2022 Q2 | 41.4 Million USD | -2.18% |
| 2022 FY | 135.37 Million USD | -22.24% |
| 2021 Q4 | 48.03 Million USD | 16.15% |
| 2021 FY | 174.08 Million USD | 23.2% |
| 2021 Q2 | 44.09 Million USD | 8.6% |
| 2021 Q3 | 41.35 Million USD | -6.21% |
| 2021 Q1 | 40.6 Million USD | -10.68% |
| 2020 Q3 | 34.46 Million USD | 0.0% |
| 2020 Q4 | 45.45 Million USD | 31.9% |
| 2020 FY | 141.3 Million USD | 27.73% |
| 2019 FY | 110.62 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 80.653% |
| Addus HomeCare Corporation | 339.87 Million USD | 61.143% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | -8.334% |
| Amedisys, Inc. | 457.07 Million USD | 71.107% |
| American Oncology Network, Inc. | 66.05 Million USD | -99.924% |
| Astrana Health, Inc. | 214.95 Million USD | 38.563% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 77.82% |
| IMAC Holdings, Inc. | 3.84 Million USD | -3331.466% |
| biote Corp. | 127.48 Million USD | -3.593% |
| Cryo-Cell International, Inc. | 22.9 Million USD | -476.664% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | 69.434% |
| COMPASS Pathways plc | -242.93 Thousand USD | 54461.195% |
| DocGo Inc. | 178.95 Million USD | 26.201% |
| The Ensign Group, Inc. | 590.75 Million USD | 77.645% |
| Healthcare Services Group, Inc. | 251.45 Million USD | 47.479% |
| Assure Holdings Corp. | -2.19 Million USD | 6119.325% |
| The Joint Corp. | 107.14 Million USD | -23.252% |
| LifeStance Health Group, Inc. | 302.09 Million USD | 56.284% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 12423.484% |
| ModivCare Inc. | 446.95 Million USD | 70.452% |
| NewGenIvf Group Limited | 1.68 Million USD | -7752.609% |
| Novo Integrated Sciences, Inc. | 4.95 Million USD | -2566.497% |
| Option Care Health, Inc. | 981.22 Million USD | 86.541% |
| P3 Health Partners Inc. | 31.63 Million USD | -317.462% |
| P3 Health Partners Inc. | 31.63 Million USD | -317.462% |
| The Pennant Group, Inc. | 61.9 Million USD | -113.33% |
| Surgery Partners, Inc. | 529.4 Million USD | 75.054% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -9253.637% |
| Talkspace, Inc. | 74.38 Million USD | -77.553% |
| Talkspace, Inc. | 74.38 Million USD | -77.553% |
| The Oncology Institute, Inc. | 59.57 Million USD | -121.684% |
| The Oncology Institute, Inc. | 59.57 Million USD | -121.684% |